Article Text

Download PDFPDF

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide
  1. P Emery1,
  2. F C Breedveld2,
  3. M Dougados3,
  4. J R Kalden4,
  5. M H Schiff5,
  6. J S Smolen6
  1. 1Department of Rheumatology and Rehabilitation, University of Leeds School of Medicine, Leeds, UK
  2. 2Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
  3. 3René Descartes University, Paris, France
  4. 4University of Erlangen-Nuremberg, Erlangen, Germany
  5. 5University of Colorado, Denver, CO, USA
  6. 6University of Vienna, Vienna, Austria
  1. Correspondence to:
    Professor P Emery, Department of Rheumatology and Rehabilitation, University of Leeds School of Medicine, 36 Clarendon Road, Leeds LS2 9NZ, UK;
    P.Emery{at}leeds.ac.uk

Abstract

Background: Effective treatment of active rheumatoid arthritis (RA) requires early diagnosis and early disease modifying antirheumatic drug (DMARD) treatment to have an impact on long term morbidity and mortality. Clinical criteria would facilitate early referral of the patient with suspected RA to a rheumatologist for definitive diagnosis and initiation of DMARD treatment at that point in the disease most likely to have an impact on the long term outcome.

Objective: To develop a referral recommendation that may serve as a clinical guide for primary care doctors, enabling them to identify patients with suspected RA during the early inflammatory stages.

Methods: Key points of the referral criteria were formed based on a thorough literature review targeting early RA, early arthritis clinics, DMARD treatment for early RA, prognostic factors of disease progression, early RA clinical trials, and quality of life. Evidence was graded using the methods defined by Shekelle et al. A draft version of the criterion was circulated among the authors for critical evaluation. A consensus integrated these comments.

Results: Clinical evidence strongly supports the observations that structural damage occurs early in active RA and that early DMARD treatment improves the long term outcome of the disease. The observations indicate that rapid referral to a rheumatologist is advised when RA is suspected. This may be supported by the presence of any of the following: ≥3 swollen joints, metatarsophalangeal/metacarpophalangeal involvement, and morning stiffness of ≥30 minutes.

Conclusion: The proposed early referral recommendation is a viable tool for primary care doctors to identify potential patients with active RA early in the disease. Early referral to a rheumatologist for definitive diagnosis and early DMARD treatment should improve the long term outcome of RA.

  • early rheumatoid arthritis
  • referral
  • early arthritis clinics
  • CRP, C reactive protein
  • DMARDs, disease modifying antirheumatic drugs
  • EACs, early arthritis clinics
  • ESR, erythrocyte sedimentation rate
  • HAQ, Health Assessment Questionnaire
  • MRI, magnetic resonance imaging
  • NSAIDs, non-steroidal anti-inflammatory drugs
  • RA, rheumatoid arthritis
  • RCTs, randomised controlled trials
  • RF, rheumatoid factor
  • US, ultrasound
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.